KR910000416B1 - 벤족사졸리논 유도체의 제조방법 - Google Patents

벤족사졸리논 유도체의 제조방법 Download PDF

Info

Publication number
KR910000416B1
KR910000416B1 KR1019830005578A KR830005578A KR910000416B1 KR 910000416 B1 KR910000416 B1 KR 910000416B1 KR 1019830005578 A KR1019830005578 A KR 1019830005578A KR 830005578 A KR830005578 A KR 830005578A KR 910000416 B1 KR910000416 B1 KR 910000416B1
Authority
KR
South Korea
Prior art keywords
benzoxazolinone
compound
hydrogen
preparing
mol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019830005578A
Other languages
English (en)
Korean (ko)
Other versions
KR840006633A (ko
Inventor
엉리 께냐르 다니엘
레스빠뇰 샤를르
레지르 다니엘
뷔쉬 노베르
Original Assignee
리옹 라보라 또 와레-세르 에스. 아.
쟝 미쉘 바르네리아
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리옹 라보라 또 와레-세르 에스. 아., 쟝 미쉘 바르네리아 filed Critical 리옹 라보라 또 와레-세르 에스. 아.
Publication of KR840006633A publication Critical patent/KR840006633A/ko
Application granted granted Critical
Publication of KR910000416B1 publication Critical patent/KR910000416B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
KR1019830005578A 1982-11-25 1983-11-25 벤족사졸리논 유도체의 제조방법 Expired KR910000416B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR19812 1982-11-25
FR8219812A FR2536749A1 (fr) 1982-11-25 1982-11-25 (amino-2 ethyl)-6 benzoxazolinones substituees, leur preparation et leurs applications en therapeutique
FR8219821 1983-01-03

Publications (2)

Publication Number Publication Date
KR840006633A KR840006633A (ko) 1984-12-01
KR910000416B1 true KR910000416B1 (ko) 1991-01-25

Family

ID=9279533

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830005578A Expired KR910000416B1 (ko) 1982-11-25 1983-11-25 벤족사졸리논 유도체의 제조방법

Country Status (17)

Country Link
US (1) US4558060A (enExample)
EP (1) EP0110781B1 (enExample)
JP (1) JPS59112976A (enExample)
KR (1) KR910000416B1 (enExample)
AT (1) ATE26270T1 (enExample)
AU (1) AU562113B2 (enExample)
CA (1) CA1208220A (enExample)
DE (1) DE3370624D1 (enExample)
DK (1) DK539983A (enExample)
ES (1) ES8501233A1 (enExample)
FI (1) FI78079C (enExample)
FR (1) FR2536749A1 (enExample)
GR (1) GR81294B (enExample)
HU (1) HU190635B (enExample)
IE (1) IE56285B1 (enExample)
PT (1) PT77735B (enExample)
ZA (1) ZA838684B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100812310B1 (ko) * 2005-12-27 2008-03-10 주식회사이에스이 위치제어용 얼라인 장치

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554284A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
US4883795A (en) * 1988-01-22 1989-11-28 Pfizer Inc. Piperazinyl-heterocyclic compounds
FR2637286A1 (fr) * 1988-10-04 1990-04-06 Adir Nouveaux derives benzoxazolinoniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2643634A1 (fr) * 1989-02-28 1990-08-31 Adir Nouveaux derives benzoxazolinoniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US5182278A (en) * 1989-02-28 1993-01-26 Adir Et Compagnie Analgesic benzoxazolinones having at the 6-position a 1-hydroxy-3-morpholinopropyl side chain
US5268381A (en) * 1990-09-26 1993-12-07 Adir Et Compagnie Aminoalkyl-benzothiazolinone and -benzoxazolinone compounds having a high 5-HT1A affinity
FR2667068B1 (fr) * 1990-09-26 1994-09-09 Adir Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5147881A (en) * 1990-11-14 1992-09-15 Pfizer Inc 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents
FR2674524B1 (fr) * 1991-03-25 1993-05-21 Adir Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5338846A (en) * 1992-08-26 1994-08-16 Pfizer Inc. Process for preparing aryl piperazinyl-heterocyclic compounds with a piperazine salt
US5206366A (en) * 1992-08-26 1993-04-27 Pfizer Inc. Process for preparing aryl piperazinyl-heterocyclic compounds
FR2717810B1 (fr) * 1994-03-22 1996-04-26 Adir Nouvelles aminoalkyl benzoxazolinones et benzothiazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
CN1182103C (zh) * 1997-08-07 2004-12-29 株式会社富吉摩托普拉泽兹 乙胺衍生物
US7213005B2 (en) * 1999-12-09 2007-05-01 International Business Machines Corporation Digital content distribution using web broadcasting services
US20040192669A1 (en) * 2000-04-13 2004-09-30 Rosenfeld Mark J. Novel compounds for use in weight loss and appetite suppression in humans
US7794761B2 (en) * 2000-04-13 2010-09-14 Seroctin Research & Technology, Inc. Methods for inducing anti-anxiety and calming effects in animals and humans
US7524877B2 (en) 2003-11-20 2009-04-28 Seroctin Research & Technology, Inc. Compounds for use in weight loss and appetite suppression in humans
EP1687300A4 (en) * 2003-11-28 2007-08-01 Wockhardt Ltd PROCESS FOR THE PREPARATION OF ZIPRASIDONE MONOHYDROCHLORIDE HYDRATE
CA2968806A1 (en) 2014-12-05 2016-06-09 Semmelweis University Use of arylalkylamine monoamine oxidase inhibitors in the treatment or prevention of cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4034100A (en) * 1976-02-13 1977-07-05 Merck & Co., Inc. Antihypertensive agents
FR2491066A1 (fr) * 1980-09-29 1982-04-02 Cerm Cent Europ Rech Mauvernay Benzoxazolinones substituees en 6 par une chaine aminoalcool ou aminocetone, leur preparation et leur application en therapeutique
FR2491471A1 (fr) * 1980-10-03 1982-04-09 Cerm Cent Europ Rech Mauvernay Benzoxazolinones substituees, leur preparation et leur application en therapeutique
JPS57123103A (en) * 1981-01-26 1982-07-31 Hokko Chem Ind Co Ltd Agricultural and horticultural fungicide
JPS61231548A (ja) * 1985-04-05 1986-10-15 Konishiroku Photo Ind Co Ltd 写真廃液の処理方法及び写真自動現像機

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100812310B1 (ko) * 2005-12-27 2008-03-10 주식회사이에스이 위치제어용 얼라인 장치

Also Published As

Publication number Publication date
DK539983A (da) 1984-05-26
EP0110781B1 (fr) 1987-04-01
FI78079C (fi) 1989-06-12
US4558060A (en) 1985-12-10
EP0110781A1 (fr) 1984-06-13
FI834315L (fi) 1984-05-26
HU190635B (en) 1986-09-29
CA1208220A (en) 1986-07-22
IE832756L (en) 1984-05-25
ZA838684B (en) 1984-07-25
AU2161283A (en) 1984-05-31
KR840006633A (ko) 1984-12-01
AU562113B2 (en) 1987-05-28
FR2536749A1 (fr) 1984-06-01
FI834315A0 (fi) 1983-11-24
DE3370624D1 (en) 1987-05-07
FI78079B (fi) 1989-02-28
ES527521A0 (es) 1984-12-01
DK539983D0 (da) 1983-11-25
ES8501233A1 (es) 1984-12-01
PT77735A (fr) 1983-12-01
ATE26270T1 (de) 1987-04-15
IE56285B1 (en) 1991-06-05
PT77735B (fr) 1986-03-27
FR2536749B1 (enExample) 1985-04-26
JPS59112976A (ja) 1984-06-29
GR81294B (enExample) 1984-12-11

Similar Documents

Publication Publication Date Title
KR910000416B1 (ko) 벤족사졸리논 유도체의 제조방법
SU852174A3 (ru) Способ получени циклоалкилтри-АзОлОВ или иХ СОлЕй
US4233303A (en) Xanthine derivatives
JPS6354321A (ja) 血糖降下剤
JPH04982B2 (enExample)
NO813066L (no) Isokinolinderivater, fremgangsmaate til deres fremstilling, farmasoeytiske tilberedninger, innhold og deres anvendelse
NO155490B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 4-)1"-hydroksy-2"-(n-imidazolyl)etyl)bibenzyl.
FR2573075A1 (fr) Nouvelles (pyridyl-2)-1 piperazines, leur procede de preparation et leur application en therapeutique
JPH0240657B2 (ja) 3*44jihidorokarubosuchirirujudotai
US4272539A (en) Pyridoindole derivatives
EP0104614B1 (en) Phenylpiperazine derivatives and process for producing the same
US5084456A (en) Oxazolopyridine compounds
EP0008652B1 (de) Neue Zwischenprodukte und deren Verwendung zur Herstellung von neuen Oxadiazolopyrimidinderivaten
CA1129854A (en) Process for the preparation of pyrimido- and imidazo derivatives
US5155116A (en) Medicinal oxazolopyridine compounds
DK154083B (da) Analogifremgangsmaade til fremstilling af halogenvincamonderivater eller optisk aktive isomere eller syreadditionssalte deraf
EP0105458B1 (en) Alpha-aryl-alpha-pyridylalkanoic acid derivatives, process for preparation thereof and pharmaceutical composition comprising the same
JPS6130588A (ja) ベンゾ〔ｃ〕〔１，８〕ナフチリジン、その製造方法及びその使用、並びにこれらの化合物を含有する調製剤
JPH03294277A (ja) ピペリジン誘導体
US5190960A (en) Medicinal oxazolopyridine compounds
US3784633A (en) Imidazolinyl-ethyl-dithiocarbamic acid esters
SE429863B (sv) Analogiforfarande for framstellning av 3-(4-(2?721-pyridyl)-piperazin-1-yl)-1-(3,4,5-trimetoxi-bensoyloxi)-propan
DE3017560A1 (de) 9-amino-6,7-dihydro-4h-pyrido eckige klammer auf 1,2-a eckige klammer zu pyrimidin-4-on-derivate, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische kompositionen
US4425351A (en) Therapeutically useful oxygen derivatives of 3,7a-diazacyclohepta[j,k]fluorenes
JPH0368576A (ja) 薬学的に活性な２―置換された３―（２―エトキシエチル）イミダゾ〔４，５―ｂ〕ピリジンおよび該化合物を含有する薬学的組成物

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19940126

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19940126